Specific ACKR2 modulators for use in therapy

Bassam Janji; Muhammad Zaeem Noman; Andy Chevigne; Martyna Szpakowska; Guy Berchem; Markus Ollert

Specific ACKR2 modulators for use in therapy

Bassam Janji (Inventor), Muhammad Zaeem Noman (Inventor), Andy Chevigne (Inventor), Martyna Szpakowska (Inventor), Guy Berchem (Inventor), Markus Ollert (Inventor)

Research output: Patent

Abstract

The application discloses a specific ACKR2 modulator for use in the treatment of a proliferative disease or disorder in a subject and/or for use in improving the response of a subject to anticancer immunotherapy. The application further discloses pharmaceutical compositions comprising such a specific ACKR2 modulator and one or more immune checkpoint inhibitors

Original language	English
Patent number	WO 2021/009251
IPC	A61K39/395; A61K48/00; A61P35/00; C07K16/28; C12N15/113
Priority date	15/07/19
Filing date	15/07/20
Publication status	Published - 21 Jan 2021

Access to Document

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2021009251

Cite this

@misc{32d5572b9b8642fcac915f1e191c683b,

title = "Specific ACKR2 modulators for use in therapy",

abstract = "The application discloses a specific ACKR2 modulator for use in the treatment of a proliferative disease or disorder in a subject and/or for use in improving the response of a subject to anticancer immunotherapy. The application further discloses pharmaceutical compositions comprising such a specific ACKR2 modulator and one or more immune checkpoint inhibitors",

author = "Bassam Janji and Noman, \{Muhammad Zaeem\} and Andy Chevigne and Martyna Szpakowska and Guy Berchem and Markus Ollert",

year = "2021",

month = jan,

day = "21",

language = "English",

type = "Patent",

note = "WO 2021/009251; A61K39/395; A61K48/00; A61P35/00; C07K16/28; C12N15/113",

}

TY - PAT

T1 - Specific ACKR2 modulators for use in therapy

AU - Janji, Bassam

AU - Noman, Muhammad Zaeem

AU - Chevigne, Andy

AU - Szpakowska, Martyna

AU - Berchem, Guy

AU - Ollert, Markus

PY - 2021/1/21

Y1 - 2021/1/21

N2 - The application discloses a specific ACKR2 modulator for use in the treatment of a proliferative disease or disorder in a subject and/or for use in improving the response of a subject to anticancer immunotherapy. The application further discloses pharmaceutical compositions comprising such a specific ACKR2 modulator and one or more immune checkpoint inhibitors

AB - The application discloses a specific ACKR2 modulator for use in the treatment of a proliferative disease or disorder in a subject and/or for use in improving the response of a subject to anticancer immunotherapy. The application further discloses pharmaceutical compositions comprising such a specific ACKR2 modulator and one or more immune checkpoint inhibitors

UR - https://worldwide.espacenet.com/patent/search/family/067437753/publication/WO2021009251A1?q=EP19186373

M3 - Patent

M1 - WO 2021/009251

Y2 - 2020/07/15

ER -

Specific ACKR2 modulators for use in therapy

Abstract

Access to Document

Other files and links

Fingerprint

Cite this